[Elsevier] SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial

fmendiluce Post time The day before yesterday 19:27 | Show all posts |Read mode
This post will be closed automatically in 2026-08-01 19:27
Reward25points


Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
ecandiota Post time The day before yesterday 19:27 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    20


Return to the list